H-ferritin engineered nanoplatform reprograms metabolism and immunity for glioblastoma immunotherapy
{{output}}
Disrupting mitochondrial metabolism and reactivating antitumor immunity offers a compelling strategy to enhance therapeutic outcomes in glioblastoma (GBM). Here, we report a mitochondria-targeting nanoplatform that integrates GBM-selective delivery, metabolic ... ...
